213 related articles for article (PubMed ID: 28438431)
1. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.
Zhang Y; Chiu T; Dubas J; Tian Z; Lee P; Gu X; Yan Y; Sher D; Timmerman R; Zhao B
Radiat Oncol; 2019 Nov; 14(1):193. PubMed ID: 31684993
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
4. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients.
Sanguineti G; Pellini R; Vidiri A; Marzi S; D'Urso P; Terrenato I; Farneti A; Fuga V; Ungania S; Landoni V
Tumori; 2021 Dec; 107(6):514-524. PubMed ID: 33821713
[TBL] [Abstract][Full Text] [Related]
6. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
7. IMRT for image-guided single vocal cord irradiation.
Osman SO; Astreinidou E; de Boer HC; Keskin-Cambay F; Breedveld S; Voet P; Al-Mamgani A; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):989-97. PubMed ID: 21300449
[TBL] [Abstract][Full Text] [Related]
8. Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
Mao W; Rozario T; Lu W; Gu X; Yan Y; Jia X; Sumer B; Schwartz DL
J Appl Clin Med Phys; 2017 Jan; 18(1):157-163. PubMed ID: 28291932
[TBL] [Abstract][Full Text] [Related]
9. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
11. The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets.
Roa DE; Schiffner DC; Zhang J; Dietrich SN; Kuo JV; Wong J; Ramsinghani NS; Al-Ghazi MS
Med Dosim; 2012; 37(3):257-64. PubMed ID: 22365418
[TBL] [Abstract][Full Text] [Related]
12. SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial.
Schwartz DL; Sosa A; Chun SG; Ding C; Xie XJ; Nedzi LA; Timmerman RD; Sumer BD
PLoS One; 2017; 12(3):e0172055. PubMed ID: 28253270
[TBL] [Abstract][Full Text] [Related]
13. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
Yu T; Wee CW; Choi N; Wu HG; Kang HC; Park JM; Kim JI; Kim JH; Kwon TK; Chung EJ
Laryngoscope; 2018 Nov; 128(11):2560-2565. PubMed ID: 29756264
[TBL] [Abstract][Full Text] [Related]
14. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study.
Versteeg AL; Hes J; van der Velden JM; Eppinga W; Kasperts N; Verkooijen HM; van Vulpen M; Oner FC; Seravalli E; Verlaan JJ
Acta Oncol; 2019 Feb; 58(2):251-256. PubMed ID: 30513233
[TBL] [Abstract][Full Text] [Related]
15. Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.
Holt A; van Vliet-Vroegindeweij C; Mans A; Belderbos JS; Damen EM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1560-7. PubMed ID: 21300461
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
[TBL] [Abstract][Full Text] [Related]
17. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
18. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
[TBL] [Abstract][Full Text] [Related]
19. Carotid sparing hypofractionated tomotherapy in early glottic cancers: Refining image guided IMRT to improve morbidity.
Chatterjee S; Guha S; Prasath S; Mallick I; Achari R
J Cancer Res Ther; 2013; 9(3):452-5. PubMed ID: 24125982
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
